As of August 20, 2026, the CDC has confirmed 2,777 measles cases for the year, with 94% linked to 36 ongoing outbreaks and the majority occurring in under-vaccinated children and adolescents. Recent weekly additions of 211 cases—driven primarily by surges in Pennsylvania and Ohio—reflect sustained community transmission in pockets of low MMR immunization coverage, consistent with patterns observed since 2025 when totals reached a 35-year high. CDC surveillance updates, typically released Thursdays, will provide the final count through August 31, incorporating any newly reported confirmed infections meeting the standard clinical and laboratory criteria. Historical data show measles' high contagiousness (R0 of 12–18) enables rapid escalation when introduction occurs in susceptible groups.
Résumé expérimental généré par IA à partir des données Polymarket. Ceci n'est pas un conseil de trading et ne joue aucun rôle dans la résolution de ce marché. · Mis à jourCas de rougeole aux États-Unis d'ici le 31 août ?
Cas de rougeole aux États-Unis d'ici le 31 août ?
NOUVEAU
31 août 2026
2800+
99%
2825+
93%
2850+
90%
$2,440 Vol.
2800+
$668 Vol.
99%
2825+
$346 Vol.
93%
2850+
$1,426 Vol.
90%
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by August 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.As of August 20, 2026, the CDC has confirmed 2,777 measles cases for the year, with 94% linked to 36 ongoing outbreaks and the majority occurring in under-vaccinated children and adolescents. Recent weekly additions of 211 cases—driven primarily by surges in Pennsylvania and Ohio—reflect sustained community transmission in pockets of low MMR immunization coverage, consistent with patterns observed since 2025 when totals reached a 35-year high. CDC surveillance updates, typically released Thursdays, will provide the final count through August 31, incorporating any newly reported confirmed infections meeting the standard clinical and laboratory criteria. Historical data show measles' high contagiousness (R0 of 12–18) enables rapid escalation when introduction occurs in susceptible groups.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by August 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Marché ouvert : Aug 24, 2026, 10:08 AM ET
Volume
$2,440Date de fin
31 août 2026Marché ouvert
Aug 24, 2026, 10:08 AM ETResolver
0x65070BE91...This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by August 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.As of August 20, 2026, the CDC has confirmed 2,777 measles cases for the year, with 94% linked to 36 ongoing outbreaks and the majority occurring in under-vaccinated children and adolescents. Recent weekly additions of 211 cases—driven primarily by surges in Pennsylvania and Ohio—reflect sustained community transmission in pockets of low MMR immunization coverage, consistent with patterns observed since 2025 when totals reached a 35-year high. CDC surveillance updates, typically released Thursdays, will provide the final count through August 31, incorporating any newly reported confirmed infections meeting the standard clinical and laboratory criteria. Historical data show measles' high contagiousness (R0 of 12–18) enables rapid escalation when introduction occurs in susceptible groups.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by August 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Volume
$2,440Date de fin
31 août 2026Marché ouvert
Aug 24, 2026, 10:08 AM ETResolver
0x65070BE91...As of August 20, 2026, the CDC has confirmed 2,777 measles cases for the year, with 94% linked to 36 ongoing outbreaks and the majority occurring in under-vaccinated children and adolescents. Recent weekly additions of 211 cases—driven primarily by surges in Pennsylvania and Ohio—reflect sustained community transmission in pockets of low MMR immunization coverage, consistent with patterns observed since 2025 when totals reached a 35-year high. CDC surveillance updates, typically released Thursdays, will provide the final count through August 31, incorporating any newly reported confirmed infections meeting the standard clinical and laboratory criteria. Historical data show measles' high contagiousness (R0 of 12–18) enables rapid escalation when introduction occurs in susceptible groups.
Résumé expérimental généré par IA à partir des données Polymarket. Ceci n'est pas un conseil de trading et ne joue aucun rôle dans la résolution de ce marché. · Mis à jour
Méfiez-vous des liens externes.
Méfiez-vous des liens externes.
Questions fréquentes